David Vaughan

566 total citations
19 papers, 371 citations indexed

About

David Vaughan is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, David Vaughan has authored 19 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in David Vaughan's work include Antibiotic Resistance in Bacteria (3 papers), Genetic Neurodegenerative Diseases (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). David Vaughan is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Genetic Neurodegenerative Diseases (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). David Vaughan collaborates with scholars based in Canada, Ireland and United States. David Vaughan's co-authors include Joseph M. Blondeau, Noël Lampron, Jayanti Mukherjee, Ronald F. Grossman, Richard J. Cook, Eric J. Bow, Anita Shah, Allen H. Heller, Roman A. Laskowski and Valery Walker and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and Critical Care Medicine.

In The Last Decade

David Vaughan

18 papers receiving 340 citations

Peers

Countries citing papers authored by David Vaughan

Since Specialization

Citations

This map shows the geographic impact of David Vaughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vaughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vaughan more than expected).

Fields of papers citing papers by David Vaughan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Vaughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vaughan. The network helps show where David Vaughan may publish in the future.

Co-authorship network of co-authors of David Vaughan

This figure shows the co-authorship network connecting the top 25 collaborators of David Vaughan. A scholar is included among the top collaborators of David Vaughan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Vaughan. David Vaughan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism 2025 ·Journal of Neurology ·David Vaughan, Raquel Real, (unknown), (unknown), (unknown), Edwin Jabbari, (unknown), (unknown), (unknown), Thomas T. Warner, Zane Jaunmuktane, Tamás Révész, James B. Rowe, Jonathan D. Rohrer, Huw R. Morris	1
2	Vocal cord paralysis as a presenting sign of autosomal recessive spinocerebellar atrophy type 10 2021 ·BMJ Case Reports ·David Vaughan, (unknown), Patrick Sheahan, Brian Sweeney	1
3	Extending the phenotype of posterior column ataxia with retinitis pigmentosa caused by variants in FLVCR1 2021 ·American Journal of Medical Genetics Part A ·David Vaughan, Daniel J. Costello	4
4	Ataxia pancytopenia syndrome due to SAMD9L mutation presenting as demyelinating neuropathy 2020 ·Journal of the Peripheral Nervous System ·David Vaughan, (unknown), Daniel J. Costello, Brian Sweeney, Brian McNamara, Richard A. Walsh, Sinéad M. Murphy	9
5	Hypoglossal palsy from an atlanto-axial synovial cyst 2020 ·Practical Neurology ·David Vaughan, Sinéad M. Murphy, Michael Alexander, Richard A. Walsh	0
6	Rheumatoid arthritis presenting as rheumatoid meningitis 2019 ·BMJ Case Reports ·Mary C. McKenna, David Vaughan, Niamh Bermingham, Simon Cronin	17
7	Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers 2010 ·Clinical Therapeutics ·David Vaughan, (unknown), Robert A. Medve, John S. Andrews	15
8	Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents 2001 ·International Journal of Antimicrobial Agents ·Joseph M. Blondeau, David Vaughan, Roman A. Laskowski, (unknown)	24
9	A review of antimicrobial resistance in Canada 2000 ·Canadian Journal of Microbiology ·Joseph M. Blondeau, David Vaughan	12
10	A review of antimicrobial resistance in Canada 2000 ·Canadian Journal of Microbiology ·Joseph M. Blondeau, David Vaughan	18
11	Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year 1999 ·PharmacoEconomics ·George W. Torrance, Valery Walker, Ronald F. Grossman, Jayanti Mukherjee, David Vaughan, (unknown), Noël Lampron	36
12	Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension 1999 ·Journal of Antimicrobial Chemotherapy ·Anita Shah, (unknown), David Vaughan, Allen H. Heller	41
13	Deciphering the oxyradical inflammation Rosetta stone 1999 ·Critical Care Medicine ·David Vaughan, Ofer Yanay, Jerry J. Zimmerman	4
14	In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study 1999 ·Journal of Antimicrobial Chemotherapy ·(unknown), Joseph M. Blondeau, (unknown), (unknown), David Vaughan	22
15	A 1-Year Community-Based Health Economic Study of Ciprofloxacin vs Usual Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis 1998 ·CHEST Journal ·Ronald F. Grossman, Jayanti Mukherjee, David Vaughan, (unknown), Richard J. Cook, (unknown), Noël Lampron	115
16	Classification, Diagnosis and Treatment of Sinusitis: Evidence‐Based Clinical Practice Guidelines 1998 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Arnold M. Noyek, (unknown), (unknown), Martin Desrosiers, Saul Frenkiel, M Hawke, James D. Kellner, (unknown), Sigmund Krajden, Donald E. Low, Lionel A. Mandell, Bernard Marlow, (unknown), (unknown), Lalitha Shankar, David Vaughan, Ian Witterick	5
17	Reduced Requirement for Antibiotic Therapy Targeting Gram-Negative Organisms in Febrile, Neutropenic Patients with Cancer Who Are Receiving Antibacterial Chemoprophylaxis with Oral Quinolones 1995 ·Clinical Infectious Diseases ·Eric J. Bow, (unknown), David Vaughan	32
18	Endomyocardial biopsy. Diagnosis of Fabry's disease in congestive cardiomyopathy. 1983 ·PubMed ·(unknown), R. M. L. Evans, Jung‐Yaw Lin, David Vaughan	3
19	Subcutaneous Abscesses in Iguanid Lizards 1970 ·Journal of the American Veterinary Medical Association ·(unknown), V. L. Sanger, (unknown), David Vaughan	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact